- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 413/12 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Patent holdings for IPC class C07D 413/12
Total number of patents in this class: 7707
10-year publication summary
|
454
|
472
|
486
|
462
|
501
|
406
|
404
|
476
|
424
|
350
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4826 |
171 |
| F. Hoffmann-La Roche AG | 7937 |
157 |
| Boehringer Ingelheim International GmbH | 4636 |
137 |
| Novartis AG | 10612 |
129 |
| AstraZeneca AB | 2857 |
99 |
| Merck Sharp & Dohme LLC | 3732 |
99 |
| Hoffmann-La Roche Inc. | 3546 |
90 |
| Takeda Pharmaceutical Company Limited | 2721 |
82 |
| Epizyme, Inc. | 375 |
79 |
| Gilead Sciences, Inc. | 2106 |
78 |
| Syngenta Participations AG | 1730 |
77 |
| Bayer AG | 3401 |
74 |
| Amgen Inc. | 4256 |
73 |
| Bayer Cropscience AG | 1983 |
72 |
| Rigel Pharmaceuticals, Inc. | 530 |
71 |
| BASF SE | 21098 |
67 |
| Janssen Pharmaceutica N.V. | 3358 |
59 |
| Merck Patent GmbH | 5752 |
58 |
| Vertex Pharmaceuticals Incorporated | 1630 |
57 |
| Shionogi & Co., Ltd. | 836 |
57 |
| Other owners | 5921 |